Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 616 | 1,103 | 2,777 | 3,269 | 3,654 |
| Cost of Goods | 491 | 731 | 1,356 | 1,781 | 1,906 |
| Gross Profit | 125 | 372 | 1,421 | 1,488 | 1,748 |
| Operating Expenses | 4,627 | 8,283 | 3,579 | 4,131 | 4,271 |
| Operating Income | -4,011 | -7,180 | -1,802 | -1,862 | -1,617 |
| Interest Expense | 251 | 144 | 80 | 65 | 44 |
| Other Income | 120 | 80 | 0 | 6 | -71 |
| Pre-tax Income | -4,142 | -7,244 | -1,882 | -1,921 | -1,732 |
| Net Income Continuous | -4,142 | -7,244 | -1,882 | -1,921 | -1,732 |
| Minority Interests | -1,188 | -765 | -690 | -766 | -718 |
| Net Income | $-2,954 | $-6,479 | $-1,192 | $-1,155 | $-1,014 |
| EPS Basic Total Ops | -0.01 | -0.02 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.02 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.02 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-4,093 | $-7,038 | $-1,666 | $-1,765 | $-1,550 |